EP0800515A1 - Dibenz (cd,f) indol-derivate - Google Patents

Dibenz (cd,f) indol-derivate

Info

Publication number
EP0800515A1
EP0800515A1 EP95943231A EP95943231A EP0800515A1 EP 0800515 A1 EP0800515 A1 EP 0800515A1 EP 95943231 A EP95943231 A EP 95943231A EP 95943231 A EP95943231 A EP 95943231A EP 0800515 A1 EP0800515 A1 EP 0800515A1
Authority
EP
European Patent Office
Prior art keywords
compound
acid addition
addition salt
dibenz
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP95943231A
Other languages
English (en)
French (fr)
Inventor
Rudolf Karl Andreas Giger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Erfindungen Verwaltungs GmbH
Ciba Geigy AG
Novartis AG
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfindungen Verwaltungs GmbH, Ciba Geigy AG, Novartis AG, Sandoz AG filed Critical Novartis Erfindungen Verwaltungs GmbH
Publication of EP0800515A1 publication Critical patent/EP0800515A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
EP95943231A 1994-12-30 1995-12-29 Dibenz (cd,f) indol-derivate Ceased EP0800515A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9426407.4A GB9426407D0 (en) 1994-12-30 1994-12-30 Improvements in or relating to organic compounds
GB9426407 1994-12-30
PCT/EP1995/005167 WO1996020927A1 (en) 1994-12-30 1995-12-29 DIBENZ[cd,f]INDOLE DERIVATIVES

Publications (1)

Publication Number Publication Date
EP0800515A1 true EP0800515A1 (de) 1997-10-15

Family

ID=10766712

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95943231A Ceased EP0800515A1 (de) 1994-12-30 1995-12-29 Dibenz (cd,f) indol-derivate

Country Status (8)

Country Link
EP (1) EP0800515A1 (de)
JP (1) JPH11504616A (de)
AU (1) AU4435896A (de)
CA (1) CA2206519A1 (de)
GB (1) GB9426407D0 (de)
IL (1) IL116606A0 (de)
WO (1) WO1996020927A1 (de)
ZA (1) ZA9511036B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0205721A (pt) 2001-07-06 2003-09-30 Endo Pharmaceuticals Inc Formulações de oximorfona de liberação controlada
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70407C (fi) * 1978-06-23 1986-09-19 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4,5,5a,6-tetra-hydro-dibens/cd f/indol derivat
BE889324A (fr) * 1980-06-27 1981-12-22 Sandoz Sa Nouveaux derives du dibenz(cd,f)indole, leur preparation et leur application comme medicaments
CH660187A5 (en) * 1983-04-06 1987-03-31 Sandoz Ag Dibenz[cd,f]indole derivatives, their preparation and the pharmaceutical compositions containing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9620927A1 *

Also Published As

Publication number Publication date
GB9426407D0 (en) 1995-03-01
IL116606A0 (en) 1996-03-31
AU4435896A (en) 1996-07-24
ZA9511036B (en) 1997-06-30
JPH11504616A (ja) 1999-04-27
CA2206519A1 (en) 1996-07-11
WO1996020927A1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
JP3048067B2 (ja) 新規方法
JPH047746B2 (de)
CZ398191A3 (en) Novel 4-amino alkyl-2(3h)-indolones and pharmaceutical compositions containing them
WO2000064898A1 (en) Azaindole derivatives for the treatment of depression
IE850117L (en) Dibenzoazepines
EP0008249B1 (de) Fluoren- und Fluoranthenderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
JP3057095B2 (ja) イサチン誘導体、その製造方法及びその使用方法
US6313309B1 (en) 4-thionaphthyl—1H—imidazoles which are usefulα22-adrenoceptoR agonists/ antagonists
CA2317515A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
FR2898358A1 (fr) Association d'un antagoniste du recepteur 5ht2 et d'activateur du recepteur 5ht2 par modulation allosterique et leurs utilisations comme produits medicaux
CH630629A5 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament.
EP0800515A1 (de) Dibenz (cd,f) indol-derivate
US6063803A (en) Octahydropyrrolo-[3,4-c]carbazoles useful as analgesic agents
FI75153C (fi) Foerfarande foer framstaellning av nya farmakologiskt aktiva (4r*,5as*)-4,5,5a,6-tetrahydro-dibens/cd,f/indolderivat.
US5641785A (en) Oxazoloquinolinone derivatives, their preparation and their therapeutic application as inhibitors of monoamine oxidase
IE50006B1 (en) Derivatives of tetrahydropyrid-4-yl-indole
LU82235A1 (fr) Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
EP0427605B1 (de) Morpholinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
NZ241341A (en) A quinolizine derivative, preparation and pharmaceutical compositions
KR20030036834A (ko) 5-페닐벤질아민 화합물, 그의 제법 및 그의 합성 중간체
EP0118566B1 (de) INDENO[1,2-b]PYRROLABKÖMMLINGE
US4602032A (en) Dibenz[cd,f]indole derivatives, their preparation and pharmaceutical compositions containing them
EP0667860B1 (de) Azaspiroalkan-derivate als therapeutika
PT89046B (pt) Processo para a preparacao de derivados de 5,6,7,8-tetra-hidro-4h-isoxazolo {4,5-c} azepina, seus isomeros e dos seus sais de adicao de acido
US4522946A (en) Dioxy hexahydrobenzo[6,7]cyclohepta[1,2,3-de]isoquinoline derivatives useful as neuroleptic agents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970603

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB IT LI

17Q First examination report despatched

Effective date: 19971128

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVARTIS-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.

Owner name: NOVARTIS AG

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19981012

RTI1 Title (correction)

Free format text: DIBENZ ??CD,F INDOLE DERIVATIVES